DLB EBITDA Growth
Dolby Laboratories Common Stock · EBITDA Growth
DLB EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-9.41%period ending
DLB TTM EBITDA YoY % (39.24% → -9.41%)
Year-over-year change
High-resolution chart · PNG
DLB ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| -9.4114% | |
| -7.405% | |
| -7.3745% | |
| -3.0042% | |
| 17.9246% | |
| 26.3286% | |
| 25.9203% | |
| 15.6957% | |
| -4.6036% | |
| -17.4322% | |
| 0.8211% | |
| 8.3663% | |
| 4.3831% | |
| 9.4336% | |
| -20.5111% | |
| -33.5668% | |
| -23.2073% | |
| -16.8405% | |
| -9.7217% | |
| 45.1976% | |
| 31.2607% | |
| 24.6087% | |
| 29.1467% | |
| -10.0256% | |
| 6.4524% | |
| 25.2507% | |
| 36.135% | |
| 32.3323% | |
| 14.1288% | |
| -28.4381% | |
| -30.5516% | |
| -18.5704% | |
| -17.4951% | |
| 16.608% | |
| 4.9524% | |
| 5.766% | |
| -1.0453% | |
| 6.5096% | |
| 15.6173% | |
| 3.1015% | |
| 15.0826% | |
| 2.3738% | |
| -6.4298% | |
| -5.1468% | |
| -7.7049% | |
| -5.1596% | |
| 6.3937% | |
| 6.9318% | |
| 3.1326% | |
| -5.2907% | |
| -18.301% | |
| -23.4398% | |
| -28.6984% | |
| -28.479% | |
| -21.2632% | |
| -16.4336% | |
| -3.5751% | |
| 1.2299% | |
| -1.994% | |
| 1.4897% | |
| 7.4519% | |
| 16.0284% | |
| 27.5317% | |
| 21.418% | |
| 11.2144% | |
| 4.9638% | |
| 38.1096% | |
| 73.9708% | |
| 85.8085% | |
| 115.3052% | |
| 22.2568% | |
| 19.2166% | |
| 15.3539% | |
| 8.8138% | |
| 47.5935% | |
| 35.9092% | |
| 55.4438% | |
| 40.8843% | |
| 56.7548% | |
| 51.9225% | |
| 4,023.9678% | |
| 570.0086% | |
| 105.8594% | |
| 33.894% | |
| -103.2259% | |
| -77.179% | |
| -20.7083% | |
| 39.245% |